Prescription Drugs Archives - Page 2 of 6

PBM Reform Momentum Heats Up

Amanda Wilke, CEBS

08 Jun 202308 Jun 2023

The fight to lower prescription drug costs is underway. Congress has introduced a handful of bipartisan bills aiming to tackle drug prices by increasing transparency on pharmacy benefit managers (PBMs) and their practices that increase drug prices for group health plans. Congressional […]

Employee Benefits Health Care Prescription Drugs

RxDC Reporting Due June 1: Here’s What to Know

Anne Newhouse, CEBS

16 May 202316 May 2023

Prescription drug data collection (RxDC) is the new reporting process required by Section 204 of the Consolidated Appropriations Act, 2021 (CAA). The reporting is meant to capture data on prescription drug (Rx) pricing trends, reimbursement amounts including rebates, identify how Rx costs […]

Diversity and Inclusion Employee Benefits Employee Benefits Survey Health Care Human Resources (HR) Insurance Prescription Drugs U.S. Wellness

The Rise of Gender-Affirmation Health Care Benefits

Anne Patterson

11 May 202318 Oct 2023

Gender-affirmation health care benefit offerings have been on the rise over the past seven years, according to survey data from the International Foundation. Up from 12 percent in 2016, 30 percent of U.S. employers now offer the benefit. I spoke with Julie […]

Affordable Care Act (ACA) Compliance DOL Employee Benefits Health Care Human Resources (HR) Insurance Prescription Drugs

**ACA Preventive Services Requirements Struck Down: Braidwood Management v. Becerra Explainer**

Jenny Gartman, CEBS

26 Apr 202326 Apr 2023

As a result of ongoing litigation, the Departments of Labor (DOL), Health and Human Services (HHS), and the Treasury (the departments) cannot enforce some Affordable Care Act (ACA) preventive care requirements, but the departments strongly encourage plan sponsors to keep coverage without […]

Employee Benefits ERISA Insurance Legislative Prescription Drugs Regulatory U.S.

Legal and Legislative Reporter: Court Denies Insurance Company’s Motion to Remand AD&D Benefits Claim

Guest Contributor

08 Feb 202310 Mar 2023

Every month, the International Foundation releases the Legal and Legislative Reporter, a compilation of new employee benefits-related case summaries. Below is a summary we thought you’d be interested in. Content provided by Morgan, Lewis & Bockius LLP. The U.S. District Court for the […]

Employee Benefits Employee Benefits Survey Health Care Prescription Drugs

Prescription Drug Cost-Containment Strategies

Justin Held, CEBS

12 Jan 202310 Mar 2023

According to a recent International Foundation survey report, health care costs are expected to increase by 7% between 2022 and 2021. This increase is driven by a number of factors, including the high cost of specialty prescription drugs. In response to the […]

Employee Benefits Employee Benefits Survey Prescription Drugs Wellness

Employers Covering Prescription Drugs for Weight Loss

Anne Patterson

05 Jan 202310 Mar 2023

A healthy reset has been a standard theme entering the new year, but it shouldn’t be the only time of year workplace wellness gets prioritized. What an individual’s weight says about their health status is an evolving discussion. So too is how […]

Employee Benefits Health Care Insurance Legislative Prescription Drugs Regulatory U.S.

RxDC Reporting Will Bring Changes . . . Here’s What to Know Now

Jonas Leyrer, CEBS

07 Dec 202207 Dec 2022

Late last year, Congress passed the Consolidated Appropriations Act, 2021 (CAA), which contained a provision requiring health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. RxDC was made retroactive for 2020 but its implementation was delayed for a […]

Compliance Employee Benefits Health Care Insurance Legislative Prescription Drugs U.S.

Health Plans and Marijuana: What to Know Now

Kathy Bergstrom, CEBS

01 Dec 202227 Jan 2023

President Joe Biden is expected to sign a medical marijuana research bill that could eventually have an impact on health plan coverage of medical marijuana. On November 16, the U.S. Senate passed Medical Marijuana and Cannabidiol Research Act, which was passed by […]

Compliance Employee Benefits Health Care Insurance Prescription Drugs U.S.

RxDC Reporting: What Plan Sponsors Need to Know

Jonas Leyrer, CEBS

04 Nov 202204 Nov 2022

RxDC Overview In late 2021, Congress passed the Consolidated Appropriations Act, 2021 (CAA) which contained a provision that requires health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. The new reporting requirement applies to most health insurance issuers […]